Global Ivermectin Injection Market Growth 2024-2030

Publication ID:

LPI04240413

Publication Date:

April 5, 2024

Pages:

129

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Organic Farming [2]

Agriculture [3]

Industry & Manufacturing [4]

Description:

The global Ivermectin Injection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the 鈥淚vermectin Injection Industry Forecast鈥� looks at past sales and reviews total world Ivermectin Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Ivermectin Injection sales for 2024 through 2030. With Ivermectin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ivermectin Injection industry.
This Insight Report provides a comprehensive analysis of the global Ivermectin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ivermectin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ivermectin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ivermectin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ivermectin Injection.
United States market for Ivermectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Ivermectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Ivermectin Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Ivermectin Injection players cover Interchemie, Durvet, Holmefield Farm Services, Hebei Hope Harmony Pharmaceutical and Boehringer Ingelheim Animal Health UK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Ivermectin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
50mL
100mL
250mL
500mL
Other
Segmentation by application
Cattle
Swine
Reindeer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Interchemie
Durvet
Holmefield Farm Services
Hebei Hope Harmony Pharmaceutical
Boehringer Ingelheim Animal Health UK
Specialist Sales
Virbac Animal Health China
Chongqing Bull Animal Pharmaceutical
Agri Direct
Premier1Supplies
VCA Animal Hospitals
Armor Animal Health
Norbrook
GEEVET REMEDIES
PBS Animal Health
AdvaCare Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ivermectin Injection market?
What factors are driving Ivermectin Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ivermectin Injection market opportunities vary by end market size?
How does Ivermectin Injection break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ivermectin Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ivermectin Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ivermectin Injection by Country/Region, 2019, 2023 & 2030
2.2 Ivermectin Injection Segment by Type
2.2.1 50mL
2.2.2 100mL
2.2.3 250mL
2.2.4 500mL
2.2.5 Other
2.3 Ivermectin Injection Sales by Type
2.3.1 Global Ivermectin Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Ivermectin Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Ivermectin Injection Sale Price by Type (2019-2024)
2.4 Ivermectin Injection Segment by Application
2.4.1 Cattle
2.4.2 Swine
2.4.3 Reindeer
2.4.4 Other
2.5 Ivermectin Injection Sales by Application
2.5.1 Global Ivermectin Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Ivermectin Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Ivermectin Injection Sale Price by Application (2019-2024)
3 Global Ivermectin Injection by Company
3.1 Global Ivermectin Injection Breakdown Data by Company
3.1.1 Global Ivermectin Injection Annual Sales by Company (2019-2024)
3.1.2 Global Ivermectin Injection Sales Market Share by Company (2019-2024)
3.2 Global Ivermectin Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Ivermectin Injection Revenue by Company (2019-2024)
3.2.2 Global Ivermectin Injection Revenue Market Share by Company (2019-2024)
3.3 Global Ivermectin Injection Sale Price by Company
3.4 Key Manufacturers Ivermectin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ivermectin Injection Product Location Distribution
3.4.2 Players Ivermectin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ivermectin Injection by Geographic Region
4.1 World Historic Ivermectin Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Ivermectin Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ivermectin Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ivermectin Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Ivermectin Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ivermectin Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ivermectin Injection Sales Growth
4.4 APAC Ivermectin Injection Sales Growth
4.5 Europe Ivermectin Injection Sales Growth
4.6 Middle East & Africa Ivermectin Injection Sales Growth
5 Americas
5.1 Americas Ivermectin Injection Sales by Country
5.1.1 Americas Ivermectin Injection Sales by Country (2019-2024)
5.1.2 Americas Ivermectin Injection Revenue by Country (2019-2024)
5.2 Americas Ivermectin Injection Sales by Type
5.3 Americas Ivermectin Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ivermectin Injection Sales by Region
6.1.1 APAC Ivermectin Injection Sales by Region (2019-2024)
6.1.2 APAC Ivermectin Injection Revenue by Region (2019-2024)
6.2 APAC Ivermectin Injection Sales by Type
6.3 APAC Ivermectin Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ivermectin Injection by Country
7.1.1 Europe Ivermectin Injection Sales by Country (2019-2024)
7.1.2 Europe Ivermectin Injection Revenue by Country (2019-2024)
7.2 Europe Ivermectin Injection Sales by Type
7.3 Europe Ivermectin Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ivermectin Injection by Country
8.1.1 Middle East & Africa Ivermectin Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ivermectin Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Ivermectin Injection Sales by Type
8.3 Middle East & Africa Ivermectin Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ivermectin Injection
10.3 Manufacturing Process Analysis of Ivermectin Injection
10.4 Industry Chain Structure of Ivermectin Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ivermectin Injection Distributors
11.3 Ivermectin Injection Customer
12 World Forecast Review for Ivermectin Injection by Geographic Region
12.1 Global Ivermectin Injection Market Size Forecast by Region
12.1.1 Global Ivermectin Injection Forecast by Region (2025-2030)
12.1.2 Global Ivermectin Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ivermectin Injection Forecast by Type
12.7 Global Ivermectin Injection Forecast by Application
13 Key Players Analysis
13.1 Interchemie
13.1.1 Interchemie Company Information
13.1.2 Interchemie Ivermectin Injection Product Portfolios and Specifications
13.1.3 Interchemie Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Interchemie Main Business Overview
13.1.5 Interchemie Latest Developments
13.2 Durvet
13.2.1 Durvet Company Information
13.2.2 Durvet Ivermectin Injection Product Portfolios and Specifications
13.2.3 Durvet Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Durvet Main Business Overview
13.2.5 Durvet Latest Developments
13.3 Holmefield Farm Services
13.3.1 Holmefield Farm Services Company Information
13.3.2 Holmefield Farm Services Ivermectin Injection Product Portfolios and Specifications
13.3.3 Holmefield Farm Services Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Holmefield Farm Services Main Business Overview
13.3.5 Holmefield Farm Services Latest Developments
13.4 Hebei Hope Harmony Pharmaceutical
13.4.1 Hebei Hope Harmony Pharmaceutical Company Information
13.4.2 Hebei Hope Harmony Pharmaceutical Ivermectin Injection Product Portfolios and Specifications
13.4.3 Hebei Hope Harmony Pharmaceutical Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hebei Hope Harmony Pharmaceutical Main Business Overview
13.4.5 Hebei Hope Harmony Pharmaceutical Latest Developments
13.5 Boehringer Ingelheim Animal Health UK
13.5.1 Boehringer Ingelheim Animal Health UK Company Information
13.5.2 Boehringer Ingelheim Animal Health UK Ivermectin Injection Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Animal Health UK Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boehringer Ingelheim Animal Health UK Main Business Overview
13.5.5 Boehringer Ingelheim Animal Health UK Latest Developments
13.6 Specialist Sales
13.6.1 Specialist Sales Company Information
13.6.2 Specialist Sales Ivermectin Injection Product Portfolios and Specifications
13.6.3 Specialist Sales Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Specialist Sales Main Business Overview
13.6.5 Specialist Sales Latest Developments
13.7 Virbac Animal Health China
13.7.1 Virbac Animal Health China Company Information
13.7.2 Virbac Animal Health China Ivermectin Injection Product Portfolios and Specifications
13.7.3 Virbac Animal Health China Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Virbac Animal Health China Main Business Overview
13.7.5 Virbac Animal Health China Latest Developments
13.8 Chongqing Bull Animal Pharmaceutical
13.8.1 Chongqing Bull Animal Pharmaceutical Company Information
13.8.2 Chongqing Bull Animal Pharmaceutical Ivermectin Injection Product Portfolios and Specifications
13.8.3 Chongqing Bull Animal Pharmaceutical Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Chongqing Bull Animal Pharmaceutical Main Business Overview
13.8.5 Chongqing Bull Animal Pharmaceutical Latest Developments
13.9 Agri Direct
13.9.1 Agri Direct Company Information
13.9.2 Agri Direct Ivermectin Injection Product Portfolios and Specifications
13.9.3 Agri Direct Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Agri Direct Main Business Overview
13.9.5 Agri Direct Latest Developments
13.10 Premier1Supplies
13.10.1 Premier1Supplies Company Information
13.10.2 Premier1Supplies Ivermectin Injection Product Portfolios and Specifications
13.10.3 Premier1Supplies Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Premier1Supplies Main Business Overview
13.10.5 Premier1Supplies Latest Developments
13.11 VCA Animal Hospitals
13.11.1 VCA Animal Hospitals Company Information
13.11.2 VCA Animal Hospitals Ivermectin Injection Product Portfolios and Specifications
13.11.3 VCA Animal Hospitals Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 VCA Animal Hospitals Main Business Overview
13.11.5 VCA Animal Hospitals Latest Developments
13.12 Armor Animal Health
13.12.1 Armor Animal Health Company Information
13.12.2 Armor Animal Health Ivermectin Injection Product Portfolios and Specifications
13.12.3 Armor Animal Health Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Armor Animal Health Main Business Overview
13.12.5 Armor Animal Health Latest Developments
13.13 Norbrook
13.13.1 Norbrook Company Information
13.13.2 Norbrook Ivermectin Injection Product Portfolios and Specifications
13.13.3 Norbrook Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Norbrook Main Business Overview
13.13.5 Norbrook Latest Developments
13.14 GEEVET REMEDIES
13.14.1 GEEVET REMEDIES Company Information
13.14.2 GEEVET REMEDIES Ivermectin Injection Product Portfolios and Specifications
13.14.3 GEEVET REMEDIES Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 GEEVET REMEDIES Main Business Overview
13.14.5 GEEVET REMEDIES Latest Developments
13.15 PBS Animal Health
13.15.1 PBS Animal Health Company Information
13.15.2 PBS Animal Health Ivermectin Injection Product Portfolios and Specifications
13.15.3 PBS Animal Health Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 PBS Animal Health Main Business Overview
13.15.5 PBS Animal Health Latest Developments
13.16 AdvaCare Pharma
13.16.1 AdvaCare Pharma Company Information
13.16.2 AdvaCare Pharma Ivermectin Injection Product Portfolios and Specifications
13.16.3 AdvaCare Pharma Ivermectin Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 AdvaCare Pharma Main Business Overview
13.16.5 AdvaCare Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂